First Light Asset Management’s OptimizeRx OPRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q4
Sell
-1,811,611
Closed -$14M 43
2024
Q3
$14M Sell
1,811,611
-15,350
-0.8% -$136K 1.16% 30
2024
Q2
$18.3M Buy
1,826,961
+89,377
+5% +$982K 1.6% 28
2024
Q1
$21.1M Buy
1,737,584
+10,286
+0.6% +$149K 1.62% 28
2023
Q4
$24.7M Sell
1,727,298
-758,749
-31% -$7.28M 1.99% 18
2023
Q3
$19.3M Buy
2,486,047
+614,248
+33% +$6.68M 1.84% 21
2023
Q2
$26.7M Buy
1,871,799
+860,868
+85% +$12.3M 2.1% 17
2023
Q1
$14.8M Buy
1,010,931
+649,655
+180% +$10.9M 1.33% 26
2022
Q4
$6.07M Sell
361,276
-2,760
-0.8% -$47.7K 0.56% 37
2022
Q3
$5.39M Buy
364,036
+3,275
+0.9% +$64.7K 0.55% 40
2022
Q2
$9.88M Buy
360,761
+30,215
+9% +$895K 1.15% 30
2022
Q1
$12.5M Buy
330,546
+16,777
+5% +$743K 1.1% 31
2021
Q4
$19.5M Sell
313,769
-193,615
-38% -$14.7M 1.4% 25
2021
Q3
$43.4M Sell
507,384
-157,458
-24% -$9.88M 2.86% 11
2021
Q2
$41.2M Buy
664,842
+70,643
+12% +$3.59M 2.47% 14
2021
Q1
$29M Sell
594,199
-91,501
-13% -$4.41M 1.92% 22
2020
Q4
$21.4M Buy
685,700
+95,700
+16% +$2.34M 1.58% 25
2020
Q3
$12.3M Hold
590,000
1.26% 25
2020
Q2
$7.69M Buy
+590,000
New +$6.41M 0.9% 32

Other funds holding OPRX

First Light Asset Management's OPRX Position: Q4 2024 in Review

First Light Asset Management sold out of OptimizeRx (OPRX) in Q4 2024, closing a stake of 1,811,611 shares — an estimated $14M sold.

First Light Asset Management first reported a position in OPRX in Q2 2020 and held it in 18 quarters. The position peaked at $43.4M in Q3 2021. 87 funds tracked by Wall St. Rank hold OPRX as of Q4 2024.

  • First Light Asset Management reported no remaining OptimizeRx position as of Q4 2024 after selling out during the quarter.
  • First Light Asset Management sold 1,811,611 OptimizeRx shares in Q4 2024, an estimated $14M.
  • First Light Asset Management first reported a position in OptimizeRx in Q2 2020 and held it in 18 quarters.
  • First Light Asset Management's OptimizeRx position peaked at $43.4M in Q3 2021.
  • 87 funds tracked by Wall St. Rank held OptimizeRx as of Q4 2024.

Based on First Light Asset Management's 13F filing for Q4 2024, filed 14 Feb 2025.